Literature DB >> 26000379

Self-assembled hyaluronate/protamine polyelectrolyte nanoplexes: synthesis, stability, biocompatibility and potential use as peptide carriers.

Anita Umerska, Krzysztof J Paluch, Maria-Jose Santos Martinez, Owen I Corrigan, Carlos Medina, Lidia Tajber.   

Abstract

This work investigates a new type of polyelectrolyte complex nanocarrier composed of hyaluronic acid (HA) and protamine (PROT). Small (approximately 60 nm) and negatively charged nanoparticles (NPs) with a polydispersity index of less than 0.2 were obtained with properties that were dependent on the mixing ratio, concentration of polyelectrolytes and molecular weight of HA. Salmon calcitonin (sCT) was efficiently (up to 100%) associated with the NPs, and the drug loading (9.6-39% w/w) was notably high, possibly due to an interaction between HA and sCT. The NPs released -70-80% of the sCT after 24 hours, with the estimated total amount of released sCT depending on the amount of HA and PROT present in the NPs. The isoelectric point of the NPs was close to pH 2, and the negative surface charge was maintained above this pH. The HA/PROT nanoplexes protected the sCT from enzymatic degradation and showed low toxicity to intestinal epithelial cells, and thus may be a promising oral delivery system for peptides.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 26000379     DOI: 10.1166/jbn.2014.1878

Source DB:  PubMed          Journal:  J Biomed Nanotechnol        ISSN: 1550-7033            Impact factor:   4.099


  4 in total

1.  Antibacterial activity of antipsychotic agents, their association with lipid nanocapsules and its impact on the properties of the nanocarriers and on antibacterial activity.

Authors:  Hassan Nehme; Patrick Saulnier; Alyaa A Ramadan; Viviane Cassisa; Catherine Guillet; Matthieu Eveillard; Anita Umerska
Journal:  PLoS One       Date:  2018-01-03       Impact factor: 3.240

2.  Surface active properties of lipid nanocapsules.

Authors:  Celia R A Mouzouvi; Anita Umerska; André K Bigot; Patrick Saulnier
Journal:  PLoS One       Date:  2017-08-10       Impact factor: 3.240

Review 3.  Enhancing the therapeutic efficacy of nanoparticles for cancer treatment using versatile targeted strategies.

Authors:  Hailong Tian; Tingting Zhang; Siyuan Qin; Zhao Huang; Li Zhou; Jiayan Shi; Edouard C Nice; Na Xie; Canhua Huang; Zhisen Shen
Journal:  J Hematol Oncol       Date:  2022-09-12       Impact factor: 23.168

4.  Nanoparticle-Mediated Angiotensin-(1-9) Drug Delivery for the Treatment of Cardiac Hypertrophy.

Authors:  Sabrina Sepúlveda-Rivas; Matías S Leal; Zully Pedrozo; Marcelo J Kogan; María Paz Ocaranza; Javier O Morales
Journal:  Pharmaceutics       Date:  2021-06-01       Impact factor: 6.321

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.